Latest News
Research & Innovation
Tobacco cessation program at Massey developed especially for cancer patients
May 28, 2020
“Quitting smoking has positive health effects for everyone, and there are so many benefits to quitting smoking for cancer patients,” said the ICAN Quit program’s co-principal investigator Brunzell. “Quitting smoking can improve the likelihood that a cancer patient’s treatment is successful, help them recover from treatment faster, lessen the side effects from treatment, potentially lengthen their survival and lower the risk of their cancer returning and the development of new cancers.”
Through ICAN Quit, Massey nurses and nurse navigators screen and triage cancer patients for tobacco use. Patients and their family household smokers or tobacco users are referred to call the Virginia Quitline, receive cessation treatment resources and medications, and/or are referred to certified tobacco treatment specialists or other counselors and clinicians trained in tobacco treatment at VCU Health. Follow-up telephone calls are made at one, three and six months after referral. Tobacco cessation print materials are distributed with messaging targeted to patients newly diagnosed with cancer, to cancer survivors and to patients who are at increased risk of dying from cancer.
To support these efforts, ICAN Quit modified Massey’s electronic medical record prompts to screen current/former tobacco users. ICAN Quit also routinely trains medical providers and clinical staff to ensure consistent and reliable assessment of tobacco use for every patient. Additionally, the program targets treatment to Massey’s unique population and aims to increase the number of certified tobacco treatment specialists who can provide evidence-based treatment. Finally, to help connect patients to evidenced-based therapies, Massey subsidizes tobacco cessation medications for its patients through the Oncology Pharmacy on a rolling basis, with social workers researching resources that may provide free/discounted medications.
“It’s never too late to quit using tobacco, even after a cancer diagnosis,” said the ICAN Quit program’s co-principal investigator Hayes. “Quitting can be hard, but the ICAN Quit program can help.”
Brunzell and Hayes will continually evaluate the program’s implementation by measuring the percentage of patients who receive tobacco screening and the percentage of providers who refer tobacco users to evidenced-based tobacco treatment. They will also evaluate population statistics for measures of tobacco use assessment and treatment on a quarterly basis and coordinate interviews with Massey medical staff to address any barriers.
For more information about the ICAN Quit program and how to quit tobacco use, visit https://www.massey.vcu.edu/patient-care/resources/tobacco-cessation/. Email icanquit@vcuhealth.org to get help with quitting from ICAN Quit.
Written by: Jenny Owen
Related News
Research & Innovation, Clinical Care, Prevention , Leadership
International community gathers for 2026 Global Cardio-Oncology Summit in WilliamsburgOct 14, 2026
Research & Innovation
Simulating cellular environments to fight advanced prostate cancerOct 7, 2026
Get access to new, innovative care
Treatments in clinical trials may be more effective or have fewer side effects than the treatments that are currently available. With more than 200 studies for multiple types of cancers and cancer prevention, Massey supports a wide array of clinical trials.
Find a provider
Massey supports hundreds of top cancer specialists serving the needs of our patients. Massey’s medical team provides a wealth of expertise in cancer diagnosis, treatment, prevention and symptom management.